Navigation Links
NeoStem to Present at Rodman & Renshaw's 11th Annual Healthcare Conference
Date:9/8/2009

NEW YORK, Sept. 8 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, announced today that Chief Executive Officer, Robin Smith, M.D., MBA, will present on the Company's latest strategic developments at Rodman & Renshaw's 11th Annual Healthcare Conference at the New York Palace Hotel in New York City on September 9-11, 2009.

Dr. Smith is scheduled to present on Wednesday, September 9, from 12:05pm to 12:30pm in the Garrison Salon on the 5th Floor.

Leading emerging growth biotechnology companies will present at the conference, which will unite companies with institutional investors, venture capitalists, senior corporate executives and experts from the scientific and medical communities.

"I am always very pleased to present at this annual conference," said Dr. Smith. "It is an opportunity to reach hundreds of the industry's most influential professionals as well as sophisticated investors looking to capitalize on next generation healthcare companies. I am especially pleased this year to talk about our expansion activities in China that will allow us to tap into a growing market in advanced stem cell therapies."

About NeoStem, Inc.

NeoStem is developing a network of adult stem cell collection centers that are focused on enabling people to donate and store their own (autologous) stem cells when they are young and healthy for their personal use in times of future medical need. The Company has also entered into research and development through the acquisition of a worldwide exclusive license to technology to identify and isolate VSELs (very small embryonic-like stem cells), which have been shown to have several physical characteristics that are generally found in embryonic stem cells and is pursuing other technologies to advance its position in the field of stem cell tissue regeneration. In 2009, the Company began to expand its operations into China in connection with the development of therapeutic adult stem cell technologies and is seeking to generate revenues through its regenerative medicine programs and technologies in China. For more information, please visit: www.neostem.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the "Risk Factors" described in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2008 and the Company's other periodic filings with the Securities and Exchange Commission. The Company's further development is highly dependent on future medical and research developments and market acceptance, which is outside its control.

    Contact:

    NeoStem, Inc.
    Robin Smith, Chief Executive Officer, 212-584-4180
    rsmith@neostem.com
    www.neostem.com


'/>"/>
SOURCE NeoStem, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NeoStem, Inc. Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs
2. NeoStem Signs Agreement for Ceres Living, Inc. to Market Innovative Nutritional Supplement Designed to Optimize Stem Cell Functions
3. NeoStem Files Patent Application for Cosmetic Stem Cell Face Lift Technology and Expands Stem Cell Collection Network into New Jersey
4. Suzanne Somers Appears on CNBCs Conversations with Michael Eisner and Discusses NeoStems Adult Stem Cell Collection Program
5. NeoStem Signs Definitive Agreement to Acquire Controlling Interest in a Leading Chinese Pharmaceutical Company
6. NeoStem, Inc. Comments on Recent Selling Pressure
7. NeoStem Signs Stem Cell Collection Agreement With University of Louisville Hospital
8. BioCryst Executives to Present at Two Investor Conferences
9. SYGNIS to Present at the 11th Rodman & Renshaw Annual Global Investment Conference
10. NHP to Present at the BMO Capital Markets 2009 North American Real Estate Conference
11. Amgen to Present at the Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... MD (PRWEB) , ... July 27, 2017 , ... ... Teams of entrepreneurs will compete to form startup companies around 117 breakthrough inventions ... Heart, Lung, and Blood Institute, and National Institute of Biomedical Imaging and Bioengineering), ...
(Date:7/27/2017)... ... July 27, 2017 , ... Cremations recently surpassed traditional burials for the ... trend is expected to continue with over 70% of Americans projected to choose cremation ... new innovations that enable families to celebrate the life of a lost loved one ...
(Date:7/26/2017)... ... 2017 , ... An inventor from Salisbury, N.C., knows the difficulties involved with ... and dignified way to keep leeches in place during therapy," she said. "That’s why ... an effective way to keep a leech in place on the skin during therapy. ...
(Date:7/26/2017)... ... July 26, 2017 , ... Written By: Ashley ... major advancement in drug therapy for patients living with relapsing and primary multiple ... novel B cell targeted therapy that has been proven to significantly reduce signs ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... Solutions as part of their continued efforts to provide innovative offerings to their ... best IT resources and build dynamic, high-performing teams to address healthcare IT’s biggest ...
Breaking Medicine News(10 mins):
(Date:7/27/2017)...  West Pharmaceutical Services, Inc. (NYSE: WST ... 2017 and updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, ... Net sales at constant currency (organic) grew by 3.9%. ... compared to $0.60 in the prior-year quarter. Second-quarter 2017 ...
(Date:7/26/2017)... Aesthetics, a leading medical aesthetic clinic in Singapore ... skin conditions from the inside. The natural process of ... skin becomes more transparent due to the thinning of the epidermis. Over ... the sun contributes to aging skin, causing age spots and other ... ...
(Date:7/26/2017)... 26, 2017 The Galien Foundation announced ... USA Award Nominees. Counted among the global ... recognizes outstanding biomedical and technology product achievement that improves the ... qualify, each candidate must be U.S. Food and Drug Administration ... demonstrate tremendous potential to impact human health. Sales data are ...
Breaking Medicine Technology: